NT-KO-003 · NT-KO-003-2010-01
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase IIa multicenter, double-blind clinical trial to evaluate the efficacy and safety of low-dose oral diazoxide for the treatment of multiple sclerosis. EudraCT: 2010-023048-34
Sponsor: NEUROTEC
Phase: II
Area: Neuroimmunology